H1B Salary Data

Home › Employers › Optum Medical Group II (Rhodes), P.C.

Optum Medical Group II (Rhodes), P.C.: H-1B salaries and sponsorship

Optum Medical Group II (Rhodes), P.C. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $355,000.

Applications (LCAs)3
Certified3
Employer addressLas Vegas, NV
H-1B dependent employerNo
Median offered salary$355,000
Middle half of salaries$355,000–$515,000
10th–90th percentile$355,000–$611,000

Does Optum Medical Group II (Rhodes), P.C. sponsor H-1B visas?

Optum Medical Group II (Rhodes), P.C. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 20, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Physician (Neurology)2$355,000
Physician (Medical Oncology)1$675,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20252$355,000
FY20261$675,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Physician (Medical Oncology)$675,000
Level IV
Las Vegas, NVApr 20, 2026Oct 1, 2026Certified
Physician (Neurology)$355,000
Level III
Las Vegas, NVJul 11, 2025Jul 21, 2025Certified
Physician (Neurology)$355,000
Level IV
Las Vegas, NVJun 26, 2025Jul 14, 2025Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).